(Q38068352)

28 August 2017

1 reference

title

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies (English)

1 reference

28 August 2017

author name string

Theodoros D Karamitsos

series ordinal

1

1 reference

28 August 2017

Stefan Neubauer

series ordinal

2

1 reference

28 August 2017

publication date

1 January 2013

1 reference

Current cardiology reports

28 August 2017

published in

1 reference

28 August 2017

volume

15

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

326

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-012-0326-2

28 August 2017

exact match

0 references

cites work

The history of cardiovascular magnetic resonance

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

The role of cardiovascular magnetic resonance imaging in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

The current and emerging role of cardiovascular magnetic resonance in the diagnosis of nonischemic cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Cardiovascular magnetic resonance in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Cardiovascular magnetic resonance imaging in myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Cardiovascular magnetic resonance in cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Detection of myocardial damage in patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

The role of cardiovascular magnetic resonance in the evaluation of valve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-012-0326-2

Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death

21 January 2018

1 reference

12 December 2020

Midwall Fibrosis Is an Independent Predictor of Mortality in Patients With Aortic Stenosis

1 reference

12 December 2020

Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function

1 reference

12 December 2020

Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping

1 reference

12 December 2020

Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy

1 reference

12 December 2020

Late enhancement: a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy?

1 reference

12 December 2020

Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis

1 reference

12 December 2020

Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery

1 reference

12 December 2020

Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease

1 reference

12 December 2020

Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction

1 reference

12 December 2020

Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance

1 reference

12 December 2020

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction

1 reference

12 December 2020

10.1007/S11886-012-0326-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1053275253

0 references

Fatcat ID

release_4wvz2k3zffegbdki4gl5s3hrxa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4wvz2k3zffegbdki4gl5s3hrxa

24 November 2022

mapped directly with Wikidata item

1 reference